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ABSTRACT
We present a method to chemically deposit a conductive polymer, poly(3,4-ethylenedioxythiophene)
(PEDOT), on acellularized muscle tissue constructs. Morphology and structure of the deposition was char-
acterized using optical and scanning electron microscopies (SEM). The micrographs showed elongated,
smooth, tubular PEDOT structures completely penetrating and surrounding the tissue fibers. The chemi-
cal polymerization was performed using iron chloride, a mild oxidizer. Remaining iron and chlorine in the
tissue constructs were reduced to acceptable metabolic levels, while preserving the structural integrity of
the tissue. We expect that these acellular, polymerized tissue implants will remain essentially unmodified
in cellular environments in vitro and in vivo because of the chemical and thermal stability of the PEDOT
polymer depositions. Our results indicate that in situ polymerization occurs throughout the tissue, con-
verting it into an extensive acellular, non-antigenic substrate of interest for in vivo experiments related to
nerve repair and bioartificial prosthesis. We expect these conducting polymer scaffolds to be useful for
direct integration with electronically and ionically active tissues.
INTRODUCTION
THE INABILITY OF biological tissues to reestablish elec-trical connectivity after injury, illness, or tumor extir-
pation can significantly affect the recovery of function in
affected individuals. This is a particularly difficult problem
in peripheral nerves, where loss of electrical continuity leads
to substantial motor and sensory deficits. Ultimately, these
peripheral nerve deficits can reduce or eliminate an indi-
vidual’s ability to be gainfully employed or even their ability
to perform typical activities of daily living. Unfortunately,
not all of these peripheral nerve injuries can be repaired
using biological tissues, and in situations involving ampu-
tations, there is no readily available and reliable way to
provide an interface between the divided peripheral nerve
stump and a prosthetic device. In these circumstances, an
enhanced interface between the biologic tissue and an allo-
plastic material would provide substantial benefits through
improved functional recovery after devastating injuries. To
improve the integration of alloplastic materials with con-
ductive tissues, we are exploring the possibility of using
conducting polymers to provide an interface with reduced
impedance for peripheral nerve regeneration.
Given the dielectric properties of most biological sam-
ples, a potential way to increase electrical conductivity is by
performing modifications with conjugated polymers to pro-
duce a final product that can decrease impedance and is bio-
compatible, electrically and thermally stable, and non-toxic.
Conjugated conducting polymers are of interest for tissue
engineering, given that new biomaterials are required to
support simultaneous tissue growth and electrical conduc-
tivity.1 Current innovations in the biomedical field include
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the use of polypyrrole2 and poly(3,4-ethylenedioxythiophene)
(PEDOT)3 or its derivatives4 for neural prosthetics. PEDOT5,6
belongs to a group of conjugated polymers known for its
good electrical conductivity due to electronic delocalization
along the polymer backbone. This conductive polymer is en-
vironmentally and electrically stable.7,8 PEDOT has been
shown to significantly reduce the impedance of biomedical
electrodes designed for long-term implantation in living tis-
sue. Its long-term chemical stability also makes it a suitable
candidate as a conductive substrate for biological tissue re-
pair. We approached this concept by modifying an acellular
muscle construct. These modified acellular constructs could
then be used for in vivo applications in peripheral nerve repair,
as well as in applications in heart muscle, skeletal muscle,
smooth muscle, and the central nervous system, where elec-
trical conductivity is critical to function.
To this end, we have engineered PEDOT-modified acel-
lular constructs, thinking that the enhanced electrical con-
ductivity would be biologically advantageous to nerve
prosthetic interfaces, nerve grafts, heart muscle patches,
or denervated skeletal muscle reinnervation. In the bio-
medical area, attempts to use conductive polymers with low-
level conductivity to help in peripheral nerve repair9 or to
form hybrid materials in cardiac tissue10 have been reported,
with successful neural recordings. For tissue repair, syn-
thetic acellularized tissue substitutes have typically been
engineered for skin,11 nerve,12 vocal fold,13 and other tis-
sues,14 in part because the use of autografts in many surgical
reconstructions is limited.
Possible solutions to the limited availability of autografts
include the use of chemically acellularized, non-synthetic
tissue allografts. Following the work of Rovak et al.,15 after
acellularization, peripheral nerves are left with a handful of
molecules, including laminin, heparan sulfate proteogly-
cans, fibronectin, and collagen IV, present on the extra-
cellular matrix (ECM) of the acellularized nerve construct.
Immunologically hyporesponsive acellular biologic con-
structs have been engineered out of peripheral nerve and
muscle.16 Acellularized muscle constructs are composed of
cytoskeleton proteins, collagen, and proteoglycans that may
be derived from allogenic tissues. Elimination of cellular
elements from the tissue permits use of the ECM mesh-
work as an allograft for implantation without the need for
immunosuppression.
In this report, we demonstrate the chemical in situ (within
the tissue) polymerization of the conductive polymer
PEDOT on acellular muscle tissue (AMT) constructs and
characterize the acellular muscle tissue with polymerized
PEDOT (AMTþ PEDOT) constructs using microscopy,
chemical analysis, and surface analysis methods. The pur-
pose of our work was to investigate the optimum conditions
for the production and manufacture of biologically inactive
tissue with a conductive coating. We used chemical oxida-
tion of the monomer 3,4-ethylenedioxylthiophene (EDOT)
with a mild oxidizer (Fe3þ) in a reaction that takes place
directly on the tissue. We also dedicated part of our efforts to
reducing the presence of iron remaining in the tissue to levels
compatible with in vivo iron metabolism. We used elemental
and qualitative chemical analysis and X-ray photoelectron
spectroscopy (XPS) characterization for this purpose.
MATERIALS AND METHODS
Materials
Iron chloride (III) was from Sigma-Aldrich (St. Louis,
MO); EDOT (>97%) monomer was from H.C. Stark
(Newton, MA); potassium ferrocyanide, hydroxylamine
hydrochloride, and 1-10-phenanthroline were from Acros
Organics (Geel, Belgium); common reagents were from
Fisher Scientific (Pittsburgh, PA).
Tissue preparation
AMT constructs were prepared from full-thickness mouse
abdominal wall muscles, as previously described,17 and
stored in a sodium azide solution. The acellularization
method is presented in Table 1. Untreated AMT constructs
were used as one type of control; in some cases, secondary
Table 1. SUMMARY OF ACELLULARIZATION METHODS INCLUDING THE COMPOSITIONS AND TIMING
Acellularizing reagent Time in reagent
A glycerol 80%/0.18% NaCl/0.05% NaN3/0.1%
EDTA
2 days, *, refill 1 more day
(3 days total)
B sodium deoxycholate 4.2%/0.05% NaN3 * 1 day
A glycerol 80%/0.9% NaCl/0.05% NaN3/0.1%
EDTA
* 2 days, *, refill 1 more day
C 1% SDS/0.05%NaN3 * 2 days
D 3% Triton X-100/0.05%NaN3 * 2 days
C 1%SDS/0.05%NaN3 * 2 days
E 0.05% NaN3 * Store in this solution indefinitely
*Between each step, solutions were drained, tissues were blotted and rinsed with water. NaCl, sodium chloride; EDTA, ethylenediamine tetraacetic
acid; SDS, sodium dodecylsulfate, NaN3, sodium azide.
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controls were prepared with AMT constructs containing iron
chloride (FeCl3) (AMTþ FeCl3) but no EDOT; test samples
were AMT constructs chemically polymerized with PEDOT
(AMTþ PEDOT), as described later.
Chemical oxidation of EDOT
In situ polymerization of EDOT was performed using
a method described elsewhere.18 First, to eliminate the
sodium azide from the untreated AMT constructs, samples
were abundantly washed and sonicated in deionized water
with repeated rinses and change of sonicated solutions with
fresh solvent. Then, as shown in Figure 1, EDOT was in situ
polymerized on mouse AMT constructs using ferric chlo-
ride oxidant in the presence of ethanol. The AMT construct
was conditioned at 208C for 20min in ethanol and EDOT
in a concentration to keep the molar ratio EDOT:FeCl3 as
1:4. Then FeCl3 was added and thoroughly mixed and kept
at 208C for 40min to slow the polymerization. The AMT
constructs were air dried overnight in a fume hood, allowing
themonomer to polymerize. SomeAMTconstructs were sub-
jected to 1 cycle of polymerization (AMTþ PEDOT1), the
others were subjected to 6 cycles of polymerization (AMTþ
PEDOT6).
Sonication
Sonication was performed to help eliminate excess iron
and chlorine from the AMT constructs after polymeriza-
tion, and different times were tested to achieve this goal.
Each polymerization cycle was performed as described
above. Between cycles, the AMT constructs were sonicated
for 2min in ethanol. After the final polymerization cycle,
the AMT constructs were rinsed with ethanol, sonicated for
30min in ethanol with solvent changes every 5 minutes,
rinsed with water, and stored in air before use in subsequent
experiments.
Construct characterization
Optical microscopy. Optical microscopy observations
were performed using a Nikon Optiphot POL (Nikon,
Tokyo, Japan) with an attached Spot RT (Diagnostic In-
struments, Sterling Heights, MI) digital camera for image
acquisition. Thin (2-3 mm) frozen sections of the sonicated
AMT, AMTþ PEDOT1, and AMTþ PEDOT6 constructs
were obtained.
Scanning electron microscopy. Observation of mor-
phology and microstructure of tissue coating in different
conditions (sonicated AMT, AMTþ PEDOT1, and AMTþ
PEDOT6 constructs and non-sonicated AMTþ PEDOT6)
was performed with a Philips/FEI XL30 ESEM instrument
(FEI Company, Hillsboro, OR). SEM micrographs were
taken with accelerating voltage of 15 kV and spot size of 3.
For SEM observation, a thin film of gold was deposited
using a common gold sputterer.
Analytical characterization. Positive presence of Fe3þ
was initially determined using potassium ferrocyanide
(Prussian Blue). Alternatively, the presence of Fe2þ was
detected with 1-10-phenanthroline19 independently and after
use of hydroxylamine hydrochlorate. These were done to
provide an initial estimate of the time frame required for
sonication. Because Prussian Blue formation is not totally
selective for iron, an additional control was performed by
oxidizing available Fe3þ present in the sample with hy-
droxylamine hydrochloride followed by the use of 1-10-
phenanthroline to identify iron in the form of a red chelate,
[Fe(phen)3]
2þ. For elemental analysis, duplicate samples
were examined for total amount of iron using a PerkinElmer
Optima 2000 ICP-OES (Inductively Coupled Plasma–
Optical Emission Spectrometer) instrument (PerkinElmer,
Waltham, MA), which is routinely used to determine iron in
biological samples. For iron, the results are given in weight
percentage and represent, for each construct type, an average
of 3 different readings at 2 different spectral wavelengths:
238.204 nm and 239.562 nm.
XPS characterization. Duplicate samples were also an-
alyzed using XPS. XPS measurements were performed
using a Kratos Axis Ultra DLD XPS (Kratos Analytical
Ltd., Manchester, UK). A monochromatic aluminum X-ray
source was used. All spectra are referenced to the C-C/C-H
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FIG. 1. Top left, chemical oxidation of 3,4-ethylenedioxy-
thiophene. Top right, scanning electron microscope image show-
ing the fibrous morphology of the mouse acellular muscle tissue
(AMT) construct (not polymerized). Bottom, optical image of wet
AMT construct before polymerization (left) and dry polymerized
AMTþ poly(3,4-ethylenedioxythiophene construct subjected to 6
cycles of polymerization (right). These images belong to different
samples and are not representative of shrinking ratios. Color im-
ages available online at www.liebertpub.com/ten.
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RESULTS
Construct preparation and chemical polymerization
We prepared the AMT constructs by polymerizing with
FeCl3 as an oxidant, leaving the polymer in the p-doped
(conductive) state. This method resulted in the deposition of
a black compound, PEDOT, on the tissue, as observed in
Figure 1. Our AMT constructs (acellular mouse abdominal
muscles) were composed of bundles of fibers (Fig. 1, top
right) and had a white yellowish coloration before poly-
merization and a dark black appearance after polymerization
(Fig. 1, bottom). The image in Figure 1 representing the
polymerized AMT construct (Fig.1, bottom right) was taken
when the tissue was completely dry (no sections were taken
in this condition), whereas the images in Figure 2 show
tissue humidified after cutting frozen sections; thus it is not
possible to directly compare the fiber size. After the che-
mical deposition of PEDOT, the previously pliable AMT
construct became stiff and brittle. The shrinking of the tissue
is readily observable by the naked eye, suggesting that the
polymer may have permeated the whole AMT construct
rather than just forming a thin layer surrounding the fibers.
This is mostly due to the drying process, but we believe that
there is a contribution to this process due to polymerization
that we have not yet quantified precisely. There is also the
potential influence of volume changes of the polymer itself
due to the exchange of counterions during oxidation.20
Optical characterization
The permeation of PEDOT into the AMT construct is
observed in the optical images shown in Figure 2. The im-
ages were taken from 2-mm longitudinal and 3-mm trans-
verse sections of AMT, AMTþ PEDOT1, and AMTþ
PEDOT6 constructs. The anisotropic structure of the AMT
construct, albeit with a directional preference along the fi-
bers, results in the anisotropic structures of the polymeri-
zation. What appear to be structural inhomogeneities of the
AMT construct are visible as a result of the color provided
by the polymer and are more visible when the amount of
polymer is smaller, for instance in the images of AMTþ
PEDOT1 constructs with 1 cycle of polymerization. These
optical images indicate that further PEDOT deposition, as
indicated by the darker color in Figure 2E and F, occurred
during multiple polymerization cycles.
Scanning electron microscopy
Observations of morphology of the AMT constructs be-
fore and after PEDOT deposition were performed using
SEM. Figure 3 shows aspects of the morphology of the po-
lymerization on the AMT construct, demonstrating that
PEDOT coatings grew thicker with increasing polymeriza-
tion cycles. All samples shown in these micrographs were
sonicated as described in Materials and Methods, with the
exceptionof someAMTþ PEDOT6constructs (micrographs
C and G), which were not sonicated. The top 2 micrographs
(A and E) correspond to control AMT constructs at low and
higher magnification. Micrographs B and F correspond to
sonicated AMTþ PEDOT1 constructs. These 2micrographs
demonstrate that the initial morphology of chemically po-
lymerized PEDOT is composed of globular particles re-
sembling the spherical particles obtained in electrochemical
polymerizations.4 However, a close observation of Figure
3F shows that some areas remain sparsely polymerized while
others are densely polymerized, indicating that, to obtain
good substrate modification and surface coverage, it was
necessary to perform additional cycles of polymerization.
FIG. 2. Optical micrographs of mouse abdominal acellular muscle tissue (AMT) samples. Top row are images taken from 3-mm
transverse sections; bottom row are images taken from 2-mm longitudinal sections, all at 40magnification. In both rows, from left to
right: (A) and (B) sonicated control AMT constructs; (C) and (D) sonicated AMTþ poly(3,4-ethylenedioxythiophene construct subjected
to 1 cycle of polymerization (PEDOT1) constructs; and (E) and (F) sonicated AMTþPEDOT6 constructs. Color images available online
at www.liebertpub.com/ten.
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Striking morphological changes can be observed at the sixth
cycle of polymerization (Fig 3C, D, G, and H). The globular
particles converted into tubes and long tree root-like fibular
structures, as seen in Figure 3H.
Chemical analysis and XPS
The results indicated that control AMT constructs did not
have substantial amounts of iron present, suggesting that
the major part of iron detected later came from the che-
mical oxidation procedure. All non-sonicated constructs
gave positive identification of Fe2þ and Fe3þ, whereas
sonicated constructs showed presence of some iron, al-
though the intensity of the color produced by the chromo-
phore decreased with longer sonication times. To facilitate
iron elimination, sonication was performed in ethanol for
2min between polymerization cycles. Iron was difficult to
observe with potassium ferrocyanide in samples that had
been sonicated for 30min in ethanol, with solvent changes
at least every 5min, but was still detected using hydroxy-
lamine hydrochloride and 1-10-phenanthroline. This indi-
cated that most of the iron not added in the dopant
backbone was reduced during polymerization. Thirty min
was considered the minimum time necessary for sonication.
FIG. 3. Scanning electron microscopy micrographs of mouse abdominal wall acellular muscle (AMT) constructs. Left column
micrographs are 2000magnification; right column are 250. Micrographs (A) and (E) show a control AMT construct, (B) and (F) an
AMTþ poly(3,4-ethylenedioxythiophene construct subjected to 1 cycle of polymerization (PEDOT1) construct, (C) and (G) a non-
sonicated AMTþ PEDOT6 construct, and (D) and (H) a sonicated AMTþ PEDOT6 construct. As observed, PEDOT in the AMT
constructs coats the muscle filaments and fills the areas between them by infiltration, working as a filler of the construct.
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The XPS technique was sensitive enough to provide ac-
curate information on the presence of the iron on the surface
of the AMT construct within the outermost 2- to 5-nm layer.
XPS is only useful for analysis of the outermost layers of the
material; for this reason, to test for the presence of oxidizer
inside the AMT constructs, we additionally performed ele-
mental analysis of whole constructs, which is discussed
below. We did not test the amount of monomer remaining
inside the construct because the chemical oxidation is per-
formed with excess oxidant over monomer.
The samples included in the spectra (Fig. 4) are sonicated
control AMT constructs (spectrum E), sonicated AMTþ
FeCl3 (spectrum C), sonicated AMTþ PEDOT1 (spectrum
B), sonicated AMTþ PEDOT6 (spectrum D), and non-
sonicated AMTþ PEDOT6 (spectrum A). No iron peak was
present in control AMT constructs (spectrum E), but there
were strong iron peaks for non-sonicated AMTþ PEDOT6
constructs (spectrum A) and for sonicated AMTþ PEDOT1
constructs (spectrum B) (*712 eV). The spectrum of
AMTþ FeCl3 showed a less-intense iron peak than non-
sonicated AMTþ PEDOT1 constructs. This effect was due
to the doping process that traps the iron in the polymer. The
peak intensities were lower for AMTþ PEDOT1 constructs
sonicated for 30min, practically at the levels of control
AMT constructs. When present, the intensity of the iron
peaks was greater than of the sulfur peaks from PEDOT,
probably because, during oxidation, a 4-M excess of iron
is used.
In the XPS spectra, the presence of the sodium peak in
control AMT constructs but not on the other constructs
indicated that some sodium was still present on the AMT
construct after the initial 2min of sonication. However, the
peak disappeared with the polymerization treatment and
further sonication procedures. For chlorine, there was a
reduction in the peak intensity; the non-sonicated samples
had a substantial presence of chlorine on the surface, but
after sonication, the chloride peak almost disappeared.
Elemental analysis of control AMT constructs gave an
average iron concentration, in percentage weight, of 0.43%,
AMTþ PEDOT1 constructs showed a 2.97% iron content,
and AMTþ PEDOT6 constructs had a 3.32% iron content.
Given the cumulative amount of iron used along the 6-time
polymerization cycle, a 6-fold average increase with re-
spect to the control samples seems a fairly reasonable in-
crease after dedoping.
DISCUSSION
We have shown that the conductive polymer PEDOT can
be chemically polymerized in a biological tissue sample.
Polymerization of PEDOT on biomedical devices has typi-
cally been performed electrochemically, a process that can-
not be achieved directly over biological tissue because of the
lack of substrate conductivity. For bulk, massive structures
or mass production, chemical oxidation is a more suitable
method for performing the polymerization.21 For biological
applications, chemical polymerization may be much better
suited, in particular in cases in which the polymerized
samples do not need to have low resistivities, as is typically
the case when PEDOT is used in industrial applications.
Chemical polymerization of EDOT can be performed
using several methods and oxidants. The classical method
employs oxidizing agents such as FeCl3
22—which is a
hazardous material—or iron (III) p-toluene sulfonate,23
which is a common oxidant but has an important drawback.
We did not use this oxidant because some of its derivatives,
namely esters, are considered to be potential alkylating
agents. Typically, PEDOT oxidation is performed in the
presence of alcohols,and the presence of any alcohol during
polymerization or later during implantation may induce the
formation of sulfonic acid esters. In particular, methyl and
ethyl methanesulfonate esters are known genotoxins and
carcinogens in rats and mice24 whereas toxicity of p-toluene
sulfonate esters has been generally established.25
Other oxidants have been used, including ferric sulfate26
or more recently enzymes.27 In our selection, we took into
account the final use of the tissue, namely its possible im-
plantation in animals and humans, and the simplicity of
preparation. Therefore, we used an oxidant that produced
reaction by-products that could be partially eliminated from
the tissue after polymerization, resulting in the partial de-
doping of the polymer. The solvent used was ethanol be-
cause it offers good conditions for solubilization of EDOT
monomer and iron chloride, although butanol could have
also been used.
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FIG. 4. X-ray photoelectron spectroscopy spectra of mouse acel-
lular muscle tissue (AMT) samples: (A) non-sonicated AMTþ
poly(3,4-ethylenedioxythiophene construct subjected to 6 cy-
cles of polymerization (PEDOT6) construct, (B) sonicated AMTþ
PEDOT1 construct, (C) sonicated AMTþ iron chloride construct,
(D) sonicated AMTþPEDOT6 construct, and (E) control AMT
construct. Color images available online at www.liebertpub
.com/ten.
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The formation of small particles after the first polymeri-
zation, as seen in Figure 3B and F, may be due to the ten-
dency of initial formation of oligomers, instead of long
polymerized chains. Additional polymerization cycles may
help in elongating the polymer chains, as seen in Figure 3D
and H. Although these elongated fibers are also visible in the
non-sonicated sample (Fig. 3C, G), they are hidden and
buried underneath a layer of deposited material, probably
composed of unreacted EDOT monomer, oligomers, and
oxidant molecules. Sonication somewhat eliminates this
layer, producing a partial dedoping of the polymerization.
Apart from the elimination of iron and chlorine, this pro-
cedure has the additional advantage of smoothing the sur-
face, reducing its roughness and asperity. The morphology
of the constructs are seen to maintain the 3-dimensional
form provided by the original piece of acellular muscle.
Muscle fiber orientation is maintained during polymeriza-
tion in all cases. In general, morphological changes are
visible from the control to polymerized samples but mac-
roscopically do not change with the number of polymeri-
zations. Microscopically, there is aggregation of polymer
and the conversion of globular PEDOT into elongated tubes.
Qualitatively, we observed a reduction in volume of the
constructs from wet non-polymerized to dry polymerized,
but the original wet size was not recovered after submersion
in water, presumably because the polymer prevented water
from reaching deep into tissue. We plan to analyze the exact
amount of polymer deposited in the constructs by using
thermogravimetric techniques that will provide the basis
for precise quantitative measurements of morphological
changes.
The amount of iron on the surface appears to be lower
after 6 polymerizations, as determined using XPS, than after
1 polymerization, even when the total iron concentrations,
from elemental analysis data, were similar. This means that
the majority of iron present in the AMT constructs is buried
inside the tissue, trapped inside the PEDOT. When used
in vivo, this may permit a slow release of iron from the
construct into the surrounding ECM in the event that the
dedoping process continues after implantation.
We introduce now a discussion on the stability of PEDOT
and its usefulness as a possible protein-masking agent, in
addition to its known use as a conductive substrate. Given
the long-term purpose of this research, namely in vivo im-
plantation of acellular AMT constructs modified with con-
ductive polymers, the emphases were put on the chemical
stability and composition of the polymerized AMT con-
structs and the elimination of iron and chlorine. We found
that, when EDOT was chemically oxidized and deposited
on the AMT construct, it formed an elongated polymeric
meshwork that surrounded the fibers but that the polymeri-
zation also took place inside them, instead of just as a thin
layer on the outer surface of the sample, as demonstrated in
the optical and SEM images. We consider that the polymer
fills the constructs, in addition to coating the filaments, as
demonstrated in the optical images in Figure 2. From this
point of view, the deposited polymer works as a filler of the
tissue, not just as a coating. The reason for this effect may be
related to the porosity of the material. Materials that are
typically used as substrates for chemical or electrochemical
oxidation of PEDOT, like platinum electrodes or fabrics,
present crystalline or fiber mesh structures where EDOT
monomers cannot penetrate or are unreachable for oxida-
tion, thus keeping the deposition of the polymer outside their
structures. In contrast, the small EDOT monomer and the
oxidant, in this case a non-bulky FeCl3 group can permeate
the loose structure of biological samples, particularly when
submersed in solvents. There seems to be good preservation
of the AMT construct structure after polymerization. In our
case, this is not a primary concern, in contrast with other
substrates like fabrics, in which the structural integrity of the
mesh must be preserved. It is unclear how this internal po-
lymerization may affect the conductivity of the AMT con-
struct differently from typical thin layer polymerizations,
because in this case it does not seem possible to polymerize
exclusively on the outer surface of the acellular construct. It
is also unclear how this internal deposition may improve the
longevity of the polymerization. Although our deposition
methods are not the same as those studied by Winther-
Jenssen,28 there generally seems to be an intrinsic increase in
the impedance of PEDOT thin films over time. Bulk, che-
mical polymerizations make the total amount of monomer
oxidized during polymerization difficult to control. Varia-
tions in the iron chloride:monomer ratio could provide a first
method to control the amount of dopant and hence, possibly,
the impedance.
There is a possibility that these polymerized structures
could eventually come off the AMT construct fibers (i.e., by
solubilization or degradation) and that isolated EDOT
monomers or whole PEDOT polymer sections could be re-
leased into the ECM of the areas surrounding the in vivo
implants, although we believe that monomer release and
PEDOT removal will not occur because of the chemical
stability of PEDOT. The PEDOT polymer backbone is not of
direct biological origin; thus its degradation by mammalian
enzymes may be difficult or impossible. In essence, because
PEDOT appears to be covering the AMT construct com-
pletely, it is masking the AMT construct proteins under-
neath. As a result, slow degradation, if any, of the polymer is
expected, thus extending the working lifetime of the im-
plant. In this sense, we propose here that PEDOT will work
to protect the AMT construct proteins from enzymatic
degradation after implantation.29 An additional advantage is
that the possible remaining antigenicity of the acellular
construct, if any, should be reduced.
Because the AMT construct itself has an inherently po-
rous, fine structure that is determined by the geometry of the
original tissue, we expect it to serve as a robust platform for
tissue regeneration and not promote the formation of a for-
eign body or encapsulation response that is seen when large,
insoluble objects are implanted in tissue. For use in pe-
ripheral nerve repair, we envision that the construct will
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more rapidly and successfully guide regenerating nerve
axons of neurotomized nerve to the transected distal nerve
stump or to muscle fibers, where they will terminate in
neuromuscular junctions. These outcomes will result in ac-
ceptable nerve function rather than allowing the axons to
grow and become painful neuromas. At this point, we do not
envision any remodeling of the AMT constructs.
Next, we briefly discuss the difficulty of the chemical
degradation of PEDOT. Chemically, EDOT is composed of
an ethylenedioxy bridge group and a thiophene ring. After
polymerization, an attack on the ethylenedioxy bridge group
will essentially convert the PEDOT backbone into a mod-
ified polythiophene backbone. To a certain degree, that may
affect the mechanical stability of the structure, leading to
solubilization or degradation of the backbone. It may also
reduce the electrical conductivity due to a reduction of the
distribution of the total charge because, in the p-doped state,
there is a stabilizing effect of the polymer produced by the
electron donor dialkoxy groups.30,31 However, substituents
in the 3 and 4 positions of the thiophene ring prevent a and
b coupling during polymerization, lowering the oxidation
potential of the monomers and stabilizing the oxidized form
of the polymers, which are not as sensitive to nucleophilic
attack as the unsubstituted materials.32
Unsubstituted thiophene belongs to a group of conjugated
compounds that are known to be resistant to ring opening,
subsequent desulfurization, and degradation.33 Chemical
modification of isolated thiophene rings is common but not
after formation of the polymer backbone. From a biological
perspective, opening of the thiophene ring may produce
undesirable degradation compounds. For instance, sulfur
oxidation in thiophene can happen when the molecule or its
derivatives are in monomeric form in biological environ-
ments.34 In the case of doped PEDOT, however, the ge-
ometry of the monomer changes and is stabilized, first, after
formation of the ethylenedioxy bridge group and, second,
after oxidation and formation of the polymer backbone,
making the polymer intractable and difficult to attack due
to steric hindrances.
So far, we have discussed the possible outcomes of the
chemical degradation of PEDOT in the AMT constructs.
Although, as we have mentioned, our initial work has the
intention of describing a method for their production, show-
ing that the manufacturing process maintains the intact
structure of the tissue and establishing a procedure for elim-
ination of the remaining oxidant, we are currently design-
ing experiments to test the cytotoxicity and conducting
properties of the construct in vitro. We are conducting our
preliminary work with a mixed culture of myoblasts and fi-
broblasts. Preliminary results indicate that these cells grow
and replicate on the plates immediately adjacent to PEDOT-
modified materials, providing early indication that the AMT
constructs have no or low cytotoxicity.
After polymerization and sonication, the amount of
FeCl3 remaining in the AMT construct, trapped as dopant
material deep inside or on the surface, was determined. The
process of iron and chlorine elimination constitutes an at-
tempt to de-dope the polymer, and it has been proven in the
past that it is not possible to eliminate the dopant com-
pletely from chemically oxidized PEDOT polymers.35 As
our results indicate, iron was mainly confined inside the
AMT construct, and the amount remaining was low, but in
any case, we decided that it was necessary to establish a
method to minimize the presence of iron in the samples
implanted in animals or humans that could be released and
accumulate in certain organs, particularly the liver, spleen,
and bone marrow. This minimization was more necessary
because of the peculiarity of the metabolism of iron in
humans, which occurs in a virtually closed system.36 Ty-
pically, little iron is absorbed from the diet (*1-2mg), and
the excretion in the urine is minimal, the absorption being
strictly controlled by the intestine to prevent toxic accu-
mulation in organs. After implantation of an acellular
construct, iron in the sample may be released and diffused
as if it were given parenterally or intravenously, depending
on the location of the implanted AMT construct and the
proximity to microvasculature, thus incorporating quickly
intro the bloodstream and accumulating, in final state, in
parenchymal cells of liver and endocrine tissues.
Although iron can be present in the samples as unreacted
Fe3þ, our results indicate that almost all iron is present as
dopant or is reduced during the polymerization process, and
thus most of the initial iron in the AMT construct will be in
its reduced state. Following the results of the elemental
analysis, and assuming that the total weight of a typical
implanted acellular AMT construct is on the range of 5 to
15mg, the absolute amount of iron implanted lies in the
range of 0.16 to 0.50mg. Thus, at a maximum, the im-
planted AMT construct will contain an amount of iron
equal to half of one day’s absorption from the diet in hu-
mans, which is a safe amount, especially when compared,
for example, with iron overload in transfusions, given that
each unit of blood contains 200 to 250mg of iron. Overall,
the results of the analysis of iron remaining on the AMT
construct samples give a strong indication that they will be
safe for implantation.
In summary, in this report, we present a method for the
chemical polymerization of the conductive polymer PEDOT
in acellularized AMT constructs. We determined that a good
method of preparing the samples for their possible use as
acellular constructs for implantation in vivo was to poly-
merize with iron chloride as the oxidant. The polymer was
partially de-doped using sonication for 30min in ethanol,
reducing iron and chlorine from the AMT constructs to
acceptable metabolic levels while preserving the structural
integrity of the AMT construct with the polymer. We ex-
pect that polymerized AMT construct implants will remain
essentially unmodified in cellular environments in vitro and
in vivo because of the chemical and thermal stability of the
PEDOT polymer depositions, providing the basis for ap-
plications in surgical reconstructions, especially in periph-
eral nerve repairs and as biosynthetic prostheses.
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